Val
—
Gro
—
Qua
—
Mom
—
Sta
—
Cap—
P/SN/A
P/E—
Fwd P/E10.54
PEG1.84
52W— – —
RSI—
Target$111.94 (+43.6%)
Beta0.75
Div2.62%
Loading chart…
RSI (14)
Loading patterns…
Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of medicines, vaccines, diagnostic products and services, biodevices, genetic tests, and precision animal health solutions for the animal health industry in the United States and internationally. The company commercializes products primarily across companion animals comprising dogs, cats, and horses; and species, including livestock, such as cattle, swine, poultry, fish, and sheep. It also offers parasiticides, vaccines, dermatology, anti-infectives, pain and sedation, other pharmaceutical, and animal health diagnostics. In addition, the company provides animal health diagnostics, including point-of-care diagnostic products, instruments and reagents, rapid immunoassay tests, reference laboratory kits and services, and blood glucose monitors; and other non-pharmaceutical products, which include nutritionals, as well as products and services in biodevices, genetic tests, and precision animal health. It markets its products to veterinarians, livestock producers, and pet owners. The company has collaborated with Blacksmith Medicines, Inc. to discover and develop novel antibiotics for animal health. Zoetis Inc. was incorporated in 2012 and is headquartered in Parsippany, New Jersey.
52-Week Range
52W Low
—
52W High
Position in Range
—
RSI (14)
0 · Oversold
RSI 55
Overbought · 100
Signal
Neutral
EMA Price Levels
Volume Analysis
Momentum Dashboard
Trend Strength
Detected Patterns
1Bullish
3Bearish
0Neutral
▲ Double Bottom — Two lows ~$71.93 — bullish reversal confirmed
▼ Bear Flag — Breakdown after -32% pole — bearish continuation
▼ Bear Flag — Breakdown after -29% pole — bearish continuation
▼ Double Top — Two peaks ~$82.09 — bearish reversal confirmed
View overlays on the price chart via Chart tab → Pattern Overlays.
EPS — History & Forecast
Estimate
Beat
Miss
Forecast
Loading…
Revenue — History & Forecast
Revenue
Forecast
Loading…
EPS Beat Rate
88%
7/8 quarters
Wall Street Consensus
BUY
BuyHoldSell
Price Target Range
$111.94
+43.6% upside
Low $80
—
High $160
Consensus
Current price
Wall Street Analyst Ratings
| Firm | Rating | Change | Action | Date |
|---|---|---|---|---|
| UBS | Neutral | — | ↔ Maintain | 2026-07-27 |
| Morgan Stanley | Overweight | — | ↔ Maintain | 2026-07-22 |
| HSBC | Buy | — | ↔ Maintain | 2026-07-06 |
| Barclays | Equal-Weight | — | ↔ Maintain | 2026-07-01 |
| TD Cowen | Buy | — | ↔ Maintain | 2026-06-30 |
| Stifel | Hold | — | ↔ Maintain | 2026-06-26 |
| Argus Research | Hold | Buy → Hold | ▼ Downgrade | 2026-05-27 |
| Citigroup | Buy | — | ↔ Maintain | 2026-05-18 |
| JP Morgan | Overweight | — | ↔ Maintain | 2026-05-08 |
| B of A Securities | Neutral | — | ↔ Maintain | 2026-02-13 |
| Piper Sandler | Neutral | Overweight → Neutral | ▼ Downgrade | 2026-01-22 |
| BTIG | Buy | — | ↔ Reiterate | 2025-12-03 |
| Keybanc | Sector Weight | — | ● Initiate | 2025-11-21 |
UBS
2026-07-27
Neutral
↔ Maintain
Morgan Stanley
2026-07-22
Overweight
↔ Maintain
HSBC
2026-07-06
Buy
↔ Maintain
Barclays
2026-07-01
Equal-Weight
↔ Maintain
TD Cowen
2026-06-30
Buy
↔ Maintain
Stifel
2026-06-26
Hold
↔ Maintain
Argus Research
2026-05-27
Hold
(from Buy)
▼ Downgrade
Citigroup
2026-05-18
Buy
↔ Maintain
JP Morgan
2026-05-08
Overweight
↔ Maintain
B of A Securities
2026-02-13
Neutral
↔ Maintain
Piper Sandler
2026-01-22
Neutral
(from Overweight)
▼ Downgrade
BTIG
2025-12-03
Buy
↔ Reiterate
Keybanc
2025-11-21
Sector Weight
● Initiate
Profitability
Gross Margin
71.84%TTM
Op. Margin
36.56%TTM
ROE
67.75%TTM
Rev. Growth
2.90%YoY
Free Cash Flow
1.78BTTM
FCF Yield
—TTM
Balance Sheet
Debt / Equity
286.24MRQ
Current Ratio
3.15MRQ
Cash
1.94BMRQ
Total Debt
9.25BMRQ
Net Debt
—MRQ
Income
Div. Yield
2.62%TTM
Annual Rate
2.12Fwd
Payout Ratio
33.28%TTM
Dividend History
Payout Ratio (TTM): 33.28%
| Date | Amount / Share | Yield at Payment |
|---|---|---|
| 2026-07-20 | $0.5300 | 0.70% |
| 2026-04-20 | $0.5300 | 0.43% |
| 2026-01-20 | $0.5300 | 0.43% |
| 2025-10-31 | $0.5000 | 0.35% |
| 2025-07-18 | $0.5000 | 0.34% |
| 2025-04-21 | $0.5000 | 0.35% |
| 2025-01-21 | $0.5000 | 0.31% |
| 2024-10-31 | $0.4320 | 0.25% |
| 2024-07-18 | $0.4320 | 0.25% |
| 2024-04-18 | $0.4320 | 0.29% |
| 2024-01-18 | $0.4320 | 0.23% |
| 2023-10-31 | $0.3750 | 0.25% |
| 2023-07-20 | $0.3750 | 0.23% |
| 2023-04-20 | $0.3750 | 0.23% |
| 2023-01-19 | $0.3750 | 0.24% |
| 2022-10-31 | $0.3250 | 0.23% |
| 2022-07-20 | $0.3250 | 0.19% |
| 2022-04-20 | $0.3250 | 0.18% |
| 2022-01-19 | $0.3250 | 0.17% |
| 2021-10-28 | $0.2500 | 0.12% |
| 2021-07-20 | $0.2500 | 0.13% |
| 2021-04-20 | $0.2500 | 0.16% |
| 2021-01-19 | $0.2500 | 0.16% |
| 2020-10-20 | $0.2000 | 0.13% |
| 2020-07-16 | $0.2000 | 0.15% |
| 2020-04-16 | $0.2000 | 0.17% |
| 2020-01-16 | $0.2000 | 0.15% |
| 2019-10-21 | $0.1640 | 0.14% |
| 2019-07-18 | $0.1640 | 0.15% |
| 2019-04-17 | $0.1640 | 0.18% |
| 2019-01-17 | $0.1640 | 0.21% |
| 2018-11-19 | $0.1260 | 0.15% |
| 2018-07-19 | $0.1260 | 0.16% |
| 2018-04-19 | $0.1260 | 0.16% |
| 2018-01-18 | $0.1260 | 0.18% |
| 2017-11-08 | $0.1050 | 0.16% |
| 2017-06-13 | $0.1050 | 0.18% |
| 2017-04-04 | $0.1050 | 0.22% |
| 2017-01-18 | $0.1050 | 0.21% |
| 2016-11-01 | $0.0950 | 0.22% |
How ZTS Makes Its Money
Cash Flow Breakdown
Quarterly Metrics
| Quarter | Revenue | Rev YoY | Gross Profit | Op. Income | Net Income | Net YoY | Gross % | Op % | Net % |
|---|
Full Key Statistics
Valuation
| Market Cap | N/A |
| Enterprise Value | 39.98B |
| Trailing P/E | 12.71 |
| Forward P/E | 10.54 |
| PEG Ratio (5yr) | 1.84 |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | N/A |
| EV/Revenue | 4.20 |
| EV/EBITDA | 9.81 |
Share Statistics
| Avg Vol (3m) | 7.54M |
| Shares Outstanding | N/A |
| Float | 418.38M |
| % Held by Insiders | 0.15% |
| % Held by Institutions | 101.42% |
| Short Ratio | 2.75 |
| Short % of Float | 5.06% |
Profitability
| Gross Margin | 71.84% |
| Operating Margin (ttm) | 36.56% |
| Profit Margin | 28.04% |
| Return on Assets (ttm) | 15.53% |
| Return on Equity (ttm) | 67.75% |
Income Statement
| Revenue (ttm) | 9.53B |
| Revenue Growth (yoy) | 2.90% |
| Gross Profit (ttm) | 6.85B |
| EBITDA | 4.07B |
| Net Income (ttm) | 2.67B |
| Diluted EPS (ttm) | 6.13 |
| EPS Growth (yoy) | 6.00% |
Balance Sheet
| Total Cash (mrq) | 1.94B |
| Total Debt (mrq) | 9.25B |
| Debt / Equity (mrq) | 286.24 |
| Current Ratio (mrq) | 3.15 |
| Book Value / Share | N/A |
| Operating CF (ttm) | 2.79B |
| Free Cash Flow (ttm) | 1.78B |
Trading & Dividends
| Beta (5Y) | 0.75 |
| 50-Day MA | 77.25 |
| 200-Day MA | 111.12 |
| Fwd Dividend Yield | 274.00% |
| Payout Ratio | 33.28% |
Ownership Breakdown
Institutional 101.42%
Insider 0.15%
Short Interest
5.06% of float
Moderate
Institutional 13F Holdings
Famous investors who disclosed a position in ZTS in their latest SEC 13F filing.
Loading…
Insider Transactions
| Date | Insider | Role | Transaction | Shares | Value |
|---|---|---|---|---|---|
| 2026-06-10 | MCCALLISTER MICHAEL B | Director | Stock Gift at price 0.00 per share. | 1,209 | — |
| 2026-05-21 | STETTER MARK | Director | 1,572 | — | |
| 2026-05-20 | PARENT LOUISE M | Director | 12,130 | — | |
| 2026-05-13 | BISARO PAUL M. | Director | Purchase at price 75.88 per share. | 2,000 | $151,750 |
| 2026-05-13 | D AMELIO FRANK A | Director | Purchase at price 75.39 per share. | 6,650 | $501,344 |
| 2026-05-11 | MCCALLISTER MICHAEL B | Director | Purchase at price 77.76 per share. | 3,000 | $233,273 |
| 2026-04-30 | ESCH KEVIN PH.D. | Officer | 259 | — | |
| 2026-03-31 | SARBAUGH KEITH | Officer | 1,528 | — | |
| 2026-03-09 | NORDEN GREGORY | Director | Stock Gift at price 0.00 per share. | 1,213 | — |
| 2026-02-19 | PECK KRISTIN C | Chief Executive Officer | 7,354 | — | |
| 2026-02-19 | D AMELIO FRANK A | Director | Conversion of Exercise of derivative security at price 127.28 per share. | 1,619 | $206,109 |
| 2026-02-19 | KHOSLA SANJAY | Director | Conversion of Exercise of derivative security at price 127.28 per share. | 1,619 | $206,109 |
| 2026-02-19 | NORDEN GREGORY | Director | 1,619 | — | |
| 2026-02-19 | REED WILLIE M | Director | 1,619 | — | |
| 2026-02-19 | MCCALLISTER MICHAEL B | Director | 1,619 | — | |
| 2026-02-19 | PARENT LOUISE M | Director | 1,619 | — | |
| 2026-02-19 | BISARO PAUL M. | Director | 1,619 | — | |
| 2026-02-19 | HATTERSLEY GAVIN D K | Director | 1,619 | — | |
| 2026-02-19 | LAGANO ROXANNE | Officer | 750 | — | |
| 2026-02-19 | FERRAN ASTORGA JEANNETTE | Officer | 431 | — | |
| 2026-02-19 | BROADHURST VANESSA | Director | 1,619 | — | |
| 2026-02-19 | ASHTON NICHOLAS | Officer | 750 | — | |
| 2026-02-19 | DRISCOLL RIMMA | Officer | 454 | — | |
| 2026-02-19 | BRANNAN JAMIE | Officer | 1,204 | — | |
| 2026-02-19 | SARBAUGH KEITH | Officer | 386 | — |
MCCALLISTER MICHAEL B
Director
Stock Gift at price 0.00 per share.
2026-06-10
1,209 sh
—
STETTER MARK
Director
2026-05-21
1,572 sh
—
PARENT LOUISE M
Director
2026-05-20
12,130 sh
—
BISARO PAUL M.
Director
Purchase at price 75.88 per share.
2026-05-13
2,000 sh
$151,750
D AMELIO FRANK A
Director
Purchase at price 75.39 per share.
2026-05-13
6,650 sh
$501,344
MCCALLISTER MICHAEL B
Director
Purchase at price 77.76 per share.
2026-05-11
3,000 sh
$233,273
ESCH KEVIN PH.D.
Officer
2026-04-30
259 sh
—
SARBAUGH KEITH
Officer
2026-03-31
1,528 sh
—
NORDEN GREGORY
Director
Stock Gift at price 0.00 per share.
2026-03-09
1,213 sh
—
PECK KRISTIN C
Chief Executive Officer
2026-02-19
7,354 sh
—
D AMELIO FRANK A
Director
Conversion of Exercise of derivative security at price 127.28 per share.
2026-02-19
1,619 sh
$206,109
KHOSLA SANJAY
Director
Conversion of Exercise of derivative security at price 127.28 per share.
2026-02-19
1,619 sh
$206,109
NORDEN GREGORY
Director
2026-02-19
1,619 sh
—
REED WILLIE M
Director
2026-02-19
1,619 sh
—
MCCALLISTER MICHAEL B
Director
2026-02-19
1,619 sh
—
PARENT LOUISE M
Director
2026-02-19
1,619 sh
—
BISARO PAUL M.
Director
2026-02-19
1,619 sh
—
HATTERSLEY GAVIN D K
Director
2026-02-19
1,619 sh
—
LAGANO ROXANNE
Officer
2026-02-19
750 sh
—
FERRAN ASTORGA JEANNETTE
Officer
2026-02-19
431 sh
—
BROADHURST VANESSA
Director
2026-02-19
1,619 sh
—
ASHTON NICHOLAS
Officer
2026-02-19
750 sh
—
DRISCOLL RIMMA
Officer
2026-02-19
454 sh
—
BRANNAN JAMIE
Officer
2026-02-19
1,204 sh
—
SARBAUGH KEITH
Officer
2026-02-19
386 sh
—